Satiety is the chosen endpoint. MN660's Unit 2 summary moves serotonin from tryptophan hydroxylase to hypothalamic 5-HT2C receptors, naming the enzyme, transporter or receptor at every stage. Searches like "mn 660 unit 2 assignment example", "mn660 unit 2 sample" and "mn660 unit 2 example" land here.
The Serotonin System Traced to Satiety: Seven Stages From Tryptophan to the Hypothalamus
[Student Name]
Purdue University Global
MN660: PMHNP Neuroscience and Psychopharmacology
Unit 2 Assignment
[Instructor Name]
[Date]
A model summary of a neurotransmitter system. No patient is described.
Why Satiety
Satiety was chosen because its receptor has been removed in knockout mice and targeted by an approved drug, so each stage can be checked against evidence. Mood, by contrast, involves many receptors and much weaker causal evidence. Following one behavior keeps every stage honest.
Seven Stages
1. Entry. Mechanism: dietary tryptophan crosses the blood-brain barrier on the large neutral amino acid transporter, competing with other large neutral amino acids for entry. Consequence: a meal rich in competing amino acids reduces tryptophan entry; a drug or diet changing that competition changes brain serotonin synthesis.
2. Synthesis, rate-limiting step. Mechanism: tryptophan hydroxylase 2, the brain isoform, converts tryptophan to 5-hydroxytryptophan. Consequence: inhibiting this enzyme depletes brain serotonin.
3. Synthesis, final step. Mechanism: aromatic L-amino acid decarboxylase converts 5-hydroxytryptophan to serotonin. Consequence: this enzyme is not rate-limiting, so supplying 5-hydroxytryptophan bypasses step 2.
4. Storage. Mechanism: VMAT2 packages serotonin into vesicles in raphe neurons. Consequence: VMAT2 inhibitors deplete stored serotonin and other monoamines.
5. Release and receptor families. Mechanism: serotonin is released from raphe terminals across the brain, including the hypothalamus. Consequence: serotonin acts on seven receptor families; 5-HT3 is the only ion channel among them, and the rest are G protein-coupled, so the focus below on one Gq-coupled subtype is a choice among many (Berger et al., 2009).
6. Reuptake and breakdown. Mechanism: the serotonin transporter recaptures most released serotonin, and monoamine oxidase A degrades the rest to 5-hydroxyindoleacetic acid. Consequence: SSRIs block the transporter and MAO inhibitors block breakdown, both raising synaptic serotonin.
7. Satiety. Mechanism: serotonin activates 5-HT2C receptors on pro-opiomelanocortin (POMC) neurons in the arcuate nucleus, which release alpha-melanocyte-stimulating hormone; that hormone acts on melanocortin 4 receptors, and meals end sooner. Consequence: a selective 5-HT2C agonist should reduce food intake. Mice lacking 5-HT2C receptors overeat and become obese (Tecott et al., 1995), and restoring the receptor only in POMC neurons is enough to normalize their feeding (Xu et al., 2008).
The Serotonin That Never Reaches the Brain
Most of the body's serotonin is made by enterochromaffin cells in the gut, not by neurons (Berger et al., 2009). It does not cross the blood-brain barrier, so gut serotonin cannot act on hypothalamic receptors, and brain serotonin must be made in the brain from tryptophan that crossed at stage 1. This is why drugs aimed at satiety act on brain receptors rather than on blood serotonin.
The Drug That Tested the Pathway
Lorcaserin, a selective 5-HT2C agonist, was approved in the United States for weight management and produced modest weight loss, consistent with stage 7. In a large cardiovascular safety trial it did not increase major cardiovascular events (Bohula et al., 2018). But a later review of the same trial found more cancers in the lorcaserin group than in the placebo group, and in 2020 the drug was withdrawn from the US market (Sharretts et al., 2020). The pathway worked as predicted; the drug failed on a safety signal unrelated to satiety.
References
Berger, M., Gray, J. A., & Roth, B. L. (2009). The expanded biology of serotonin. Annual Review of Medicine, 60, 355-366. https://doi.org/10.1146/annurev.med.60.042307.110802
Bohula, E. A., Wiviott, S. D., McGuire, D. K., Inzucchi, S. E., Kuder, J., Im, K., Fanola, C. L., Qamar, A., Brown, C., Budaj, A., Garcia-Castillo, A., Gupta, M., Leiter, L. A., Weissman, N. J., White, H. D., Patel, T., Francis, B., Miao, W., Perdomo, C., ... Scirica, B. M. (2018). Cardiovascular safety of lorcaserin in overweight or obese patients. New England Journal of Medicine, 379(12), 1107-1117. https://doi.org/10.1056/NEJMoa1808721
Sharretts, J., Galescu, O., Gomatam, S., Andraca-Carrera, E., Hampp, C., & Yanoff, L. (2020). Cancer risk associated with lorcaserin: The FDA's review of the CAMELLIA-TIMI 61 trial. New England Journal of Medicine, 383(11), 1000-1002. https://doi.org/10.1056/NEJMp2003873
Tecott, L. H., Sun, L. M., Akana, S. F., Strack, A. M., Lowenstein, D. H., Dallman, M. F., & Julius, D. (1995). Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors. Nature, 374(6522), 542-546. https://doi.org/10.1038/374542a0
Xu, Y., Jones, J. E., Kohno, D., Williams, K. W., Lee, C. E., Choi, M. J., Anderson, J. G., Heisler, L. K., Zigman, J. M., Lowell, B. B., & Elmquist, J. K. (2008). 5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis. Neuron, 60(4), 582-589. https://doi.org/10.1016/j.neuron.2008.09.033
How this MN660 Unit 2 example is structured
A two-sentence frame states why satiety was chosen: its receptor has been removed in knockout mice and targeted by an approved drug, which lets every stage be checked against evidence. The seven numbered blocks follow in anatomical order, synthesis to effect, and each keeps the same two lines so that a missing consequence stands out. A sidebar on receptor families sits after the release block, listing the seven families and marking 5-HT3 as the only ion channel among them, so that the later focus on one Gq-coupled subtype reads as a choice. The satiety block then follows signal to behavior: 5-HT2C activation on POMC neurons, alpha-MSH release, melanocortin 4 receptors, smaller meals. A closing paragraph cites lorcaserin as the drug that tested this pathway in people and reports its 2020 withdrawal from the US market after a cancer imbalance in a safety trial.
Get an MN660 Unit 2 example written to your instructions
Which serotonin receptor or behavior has the Unit 2 prompt chosen, or is the system itself left open? Tell us along with the rubric, and a free first summary follows those instructions in 24-48h, tracing synthesis to behavior in numbered stages. Dopamine, norepinephrine and glutamate systems fit the same format if your section assigns one of those instead. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
MN660 Unit 2 questions, answered
Can the summary use mood or depression as the behavior?
It can, provided the evidence is described honestly. Serotonin's link to mood is real but indirect, and a summary presenting low serotonin as the cause of depression usually loses marks. Satiety, nausea or sleep offer cleaner receptor-to-behavior chains. If your prompt names mood, treat serotonin as one input to circuits rather than as a deficit waiting to be topped up.
How many receptor subtypes should be covered?
Fewer than most students expect. A brief overview of the seven families helps orientation, but credit usually follows the subtype carried through to a behavior with its signaling mechanism explained. Listing fourteen receptors without saying what any of them does inside a cell reads as memorization, while one receptor explained completely shows the understanding the rubric is built around.
Is a diagram expected?
Often, and a flow diagram from synthesis to effect suits this assignment well. Label each arrow with the enzyme, transporter or receptor responsible, and keep the prose alongside it doing the explaining. If you adapt a published figure, credit it in the caption. A diagram without text explaining each stage tends to earn only partial credit.